Signal cell seqencing of primary HCMV infections
Signal cell seqencing of primary HCMV infections
批准号:
10218861
负责人:
TIMOTHY F KOWALIK
金额:
$25.13万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-01 至 2023-02-28
关键词:
3-DimensionalAcquired Immunodeficiency SyndromeAcuteAdolescentAntigensAntiviral AgentsBiological ModelsBreast FeedingCell Differentiation processCell physiologyCellsCessation of lifeCongenital AbnormalityCytomegalovirusCytomegalovirus InfectionsDevelopmentDiscipline of NursingDiseaseEpithelial CellsEventFetusFibroblastsGanciclovirGene ExpressionGeneticHematopoietic stem cellsHerpesviridaeHumanHuman MilkImmuneImmune responseImmunologic Deficiency SyndromesIn VitroIndividualInfectionInnate Immune ResponseInterventionKnowledgeLactationMediatingMethodologyMorbidity - disease rateMothersNursing infantOpportunistic InfectionsOralOral cavityOrganPatientsPlasmaPregnant WomenPrimary InfectionProtocols documentationRiskSensorineural Hearing LossSevere Combined ImmunodeficiencySignal TransductionSolidSourceSpontaneous abortionSwabTechnologyTeratogensTestingTissue ModelTissuesTransplant RecipientsUmbilical Cord Blood TransplantationVaccinesVertical Disease TransmissionViral GenesVirusVirus ReplicationVirus SheddingWomanacquired immunodeficiencycell typeclinically relevantcongenital infectiondata analysis pipelinefetus at riskimprovedin uteroin vivoinfection rateinfluenza infectioninsightmortalitynoveloral cavity epitheliumoral infectionpathogenpreventresponsesingle cell sequencingsingle-cell RNA sequencingthree dimensional cell culturetooltranscriptometransmission processviral resistance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is a herpesvirus commonly found in humans. HCMV infections are lifelong and usually do not have an apparent burden on the host. In individuals with natural or acquired immunodeficiency, HCMV can be a significant cause of disease and even death. HCMV is also the leading infectious cause of birth defects. How the virus infects a new host (primary infection) is poorly understood, especially in transmissions that occur during nursing. Lactating women who are positive for HCMV—which, globally, represents most women—shed virus in breast milk. About 4 in 10 women with HCMV will transmit the virus to their nursing infant. How this transmission occurs and the identity of cells in the oral cavity that become infected are poorly understood. Here we adapt cutting edge single cell RNA sequencing technology to identify which cells are infected in the oral cavity of nursing infants and determine the consequences of this infection on an individual cell basis. This approach allows us to propose a hypothesis that HCMV preferentially infects subsets of epithelial cells during oral primary infections that impact replication and host innate responses. We will test this hypothesis across two aims. The first, will adapt the single cell RNA sequencing technology to HCMV infected cultures of 3D oral epithelia tissues. The second aim will apply the technology to analyze primary infections in the oral cavity of nursing infants. These novel studies will provide new knowledge into HCMV primary infections and inform the development of improved interventions that prevent HCMV transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HCMV receptors, signaling and entry
-
批准号:10669505
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2022
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Signal cell seqencing of primary HCMV infections
-
批准号:10358609
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2021
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
CMV meeting support
-
批准号:8130117
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2011
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
12th International Cytomegalovirus and Beta-Herpesvirus Workshop
-
批准号:7675912
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7459591
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:8090262
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7898886
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7320328
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7650326
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6706278
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6628465
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6497996
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6350444
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6097365
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
海外基金